Companies Push Ahead with Prediction Market Investments Amid Regulatory Uncertainty Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Morning Market Movers Buffetts Tiny Purchase Hinted at in March Berkshire Filing Suggests Small New Position Gold Prices Decline as Fed Governor Waller Signals Potential Rate Hike Amid Iran War Energy Shock AbbVie Inc Positioned for LongTerm Growth with IBD Pipeline Strength Micron and SK Hynix Reportedly Surpass 1 Trillion Market Cap Amid AI Chip Boom Playtika Q1 2026 Earnings EPS Misses Estimates by 518 as Stock Declines Tompkins Financial Corporation TMP Q1 2026 Earnings EPS Beats Estimates Despite Stock Decline INTC Q1 2026 Earnings Major EPS Beat Amid Mixed Signals CBNA Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback Cass Information Systems Q1 2026 Earnings EPS Beat by Nearly 6 but Stock Slips on Missing Revenue Details Apple Hospitality REIT APLE Rises 152 Testing Key Resistance After Support Hold DuPont DD Surges 36 Analyzing the Breakout and Key Levels Gabelli MultiMedia Trust GGT Holds Steady at 427 Amid Quiet Trading Janus Henderson Group JHG Holds Steady Near 52 as Key Levels Loom Franklin Limited Duration Income Trust FTF Edges Higher as Yield Seekers Reassess Rate Outlook Dropbox CEO Drew Houston to Step Down After 19Year Tenure Becomes Executive Chairman AllianceBernstein Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Alpine Income Property Trust PINE Gains 15 Approaches Key Resistance at 2056 Blackbaud Inc BLKB Q1 2026 Earnings Narrow EPS Beat Amid Modest Stock Recovery AudioCodes Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction UUU Q4 2024 Earnings Widened Loss Amidst Challenging Market Conditions EDUC Q1 2026 Earnings Educational Development Corporation Reports Loss Amidst Unclear Revenue Picture BBT Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower CGON Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain